Skip to main content
Top
Published in: Clinical Rheumatology 5/2007

01-05-2007 | Original Article

The changes in monosaccharide composition of immunoglobulin G in the course of rheumatoid arthritis

Authors: Ewa Gindzienska-Sieskiewicz, Piotr Adrian Klimiuk, Dariusz Gabriel Kisiel, Andrzej Gindzienski, Stanislaw Sierakowski

Published in: Clinical Rheumatology | Issue 5/2007

Login to get access

Abstract

The objective of this study was to determine whether galactosylation of immunoglobulin G (IgG) in patients with rheumatoid arthritis (RA) correlates with severity and duration of illness. Serum IgG glycosylation from 50 patients with RA in comparison with 30 healthy controls was analyzed. IgG from sera was isolated and monosaccharide composition was determined by means of gas chromatography. Ratio of galactose to mannose content was calculated. Patients were divided into groups according to three different criteria: disease duration, severity of RA (disease activity score index), and radiological degree of advancement of illness according to Steinbrocker. In patients with RA, significant decrease (p<0,01) of galactose ratio was observed in comparison with healthy control. In patients with long duration of RA (more than 15 years), significant decrease of galactose (p<0.05) ratio in comparison with patients who have had arthritis for less then 5 years was observed. For the group of patients with severe RA, we found reduction of galactose (p<0.001) ratio vs the group of patients in remission. For those patients who had radiological stage IV according to Steinbrocker, IgG galactose (p<0.01) content per oligosaccharide chain were also more decreased than in those patients who had stage I RA. Decreased galactosylation and of IgG in RA was observed. The lack of this carbohydrate component of IgG correlates with severity and duration of RA and could be used in monitoring the progression in early arthritis.
Literature
1.
go back to reference Mackiewicz S, Hrycaj P (1995) Rheumatoid arthritis. In: Mackiewics S, Zimmermann-Gorska I (eds) Reumatologia, PZWL, Warsaw pp 87–101 Mackiewicz S, Hrycaj P (1995) Rheumatoid arthritis. In: Mackiewics S, Zimmermann-Gorska I (eds) Reumatologia, PZWL, Warsaw pp 87–101
2.
go back to reference Berger E (1996) How are oligosaccharides synthesized? Eur J Biochem 25–27 Berger E (1996) How are oligosaccharides synthesized? Eur J Biochem 25–27
3.
go back to reference Watson M, Rudd PM, Bland M, Dwek RA, Axford J (1999) Sugar printing rheumatic diseases. A potential method for disease differentiation using immunoglobulin G oligosaccharides. Arthritis Rheum 42:1682–1690PubMedCrossRef Watson M, Rudd PM, Bland M, Dwek RA, Axford J (1999) Sugar printing rheumatic diseases. A potential method for disease differentiation using immunoglobulin G oligosaccharides. Arthritis Rheum 42:1682–1690PubMedCrossRef
4.
go back to reference Palamarczyk G (1987) Heterogennoœæ struktury reszt cukrowych N-glikoprotein jako wynik procesów kotranslacyjnych. Post Bioch 33:297–307 Palamarczyk G (1987) Heterogennoœæ struktury reszt cukrowych N-glikoprotein jako wynik procesów kotranslacyjnych. Post Bioch 33:297–307
5.
go back to reference Alavi A, Arden N, Spector TD, Axford JS (2000) Immunoglobulin G glycosylation and clinical outcome in rheumatoid arthritis during pregnancy. J Rheumatol 27:1379–1385PubMed Alavi A, Arden N, Spector TD, Axford JS (2000) Immunoglobulin G glycosylation and clinical outcome in rheumatoid arthritis during pregnancy. J Rheumatol 27:1379–1385PubMed
6.
go back to reference Bond A, Alavi A, Axford JS, Bourke BE, Brukner FE, Kerr MA, Maxwell JD, Youinou P, Hay FC (1997) A detailed lectin analysis of IgG glycosylation, demonstrating disease specific changes in terminal galactose and N-acetyloglucosoamine. J Autoimmun 10:77–85PubMedCrossRef Bond A, Alavi A, Axford JS, Bourke BE, Brukner FE, Kerr MA, Maxwell JD, Youinou P, Hay FC (1997) A detailed lectin analysis of IgG glycosylation, demonstrating disease specific changes in terminal galactose and N-acetyloglucosoamine. J Autoimmun 10:77–85PubMedCrossRef
8.
go back to reference Axford JS, Sumar N, Alavi A, Isenberg DA, Young A, Bodman KB, Roitt IM (1992) Changes in normal glycosylation mechanism in autoimmune rheumatic disease. J Clin Invest 89:1021–1031PubMedCrossRef Axford JS, Sumar N, Alavi A, Isenberg DA, Young A, Bodman KB, Roitt IM (1992) Changes in normal glycosylation mechanism in autoimmune rheumatic disease. J Clin Invest 89:1021–1031PubMedCrossRef
9.
go back to reference Bond A, Alavi A, Axford JS, Youinou P, Hay FC (1996) The relationship between exposed galactose and N-acetylglucosamine residues on IgG in rheumatoid arthritis, juvenile chronic arthritis and Sjögren’s syndrome. Clin Exp Immunol 105:99–103PubMedCrossRef Bond A, Alavi A, Axford JS, Youinou P, Hay FC (1996) The relationship between exposed galactose and N-acetylglucosamine residues on IgG in rheumatoid arthritis, juvenile chronic arthritis and Sjögren’s syndrome. Clin Exp Immunol 105:99–103PubMedCrossRef
10.
go back to reference Tomana M, Schrohenloher RE, Koopman WJ, Alarcon GS, Paul WA (1998) Abnormal glycosylation of serum IgG from patients with chronic inflammatory diseases. Arthritis Rheum 31:418–419 Tomana M, Schrohenloher RE, Koopman WJ, Alarcon GS, Paul WA (1998) Abnormal glycosylation of serum IgG from patients with chronic inflammatory diseases. Arthritis Rheum 31:418–419
11.
go back to reference Axford JS, Lydyard PM, Isenberg DA, Mackenzie L, Hay FC, Roitt IM (1987) Reduced B-cell galactosyltransferase activity in rheumatoid arthritis. Lancet 26:1186–1192 Axford JS, Lydyard PM, Isenberg DA, Mackenzie L, Hay FC, Roitt IM (1987) Reduced B-cell galactosyltransferase activity in rheumatoid arthritis. Lancet 26:1186–1192
12.
go back to reference Axford JS (1997) The importance of oligosaccharides to rheumatic disease: a personal perspective. Glycoconj J 14:863–866PubMedCrossRef Axford JS (1997) The importance of oligosaccharides to rheumatic disease: a personal perspective. Glycoconj J 14:863–866PubMedCrossRef
13.
14.
go back to reference Dwek RA (1996) Glycobiology: towards understanding the function of sugars. Chem Rev 96:638–720CrossRef Dwek RA (1996) Glycobiology: towards understanding the function of sugars. Chem Rev 96:638–720CrossRef
15.
go back to reference Klama K, Lacki JK, Müller W, Mackiewicz SH (1996) The abnormalities in the glycosylation of IgG. Reumatologia 34:26–30 Klama K, Lacki JK, Müller W, Mackiewicz SH (1996) The abnormalities in the glycosylation of IgG. Reumatologia 34:26–30
16.
go back to reference Madhok R, Cappell HA (1988) Galactose residues in chronic inflammatory disease (letter). Lancet 8582:418CrossRef Madhok R, Cappell HA (1988) Galactose residues in chronic inflammatory disease (letter). Lancet 8582:418CrossRef
17.
go back to reference Axford JS, Mackenzie L, Lydyard PM, Hay FC, Isenberg DA, Roitt IM (1988) Galactose residues in chronic inflammatory (reply). Lancet 8582:418 Axford JS, Mackenzie L, Lydyard PM, Hay FC, Isenberg DA, Roitt IM (1988) Galactose residues in chronic inflammatory (reply). Lancet 8582:418
18.
go back to reference Lucey MD, Newkirk BM, Roitt IM, Dwek RA, Rademacher TW (2000) Association between IgM response to IgG damaged by glyoxidation and disease activity in rheumatoid arthritis. J Rheumatol 27:319–323PubMed Lucey MD, Newkirk BM, Roitt IM, Dwek RA, Rademacher TW (2000) Association between IgM response to IgG damaged by glyoxidation and disease activity in rheumatoid arthritis. J Rheumatol 27:319–323PubMed
19.
go back to reference Parekh RB, Isenberg DA, Ansell BM, Roitt IM, Dwek RA, Rademacher TW (1988) Galactosylation of IgG associated oligosaccharides: Reduction in patients with adult and juvenile onset rheumatoid arthritis and relation to disease activity. The Lancet 1(8592):966–969 (April 30)CrossRef Parekh RB, Isenberg DA, Ansell BM, Roitt IM, Dwek RA, Rademacher TW (1988) Galactosylation of IgG associated oligosaccharides: Reduction in patients with adult and juvenile onset rheumatoid arthritis and relation to disease activity. The Lancet 1(8592):966–969 (April 30)CrossRef
20.
go back to reference Young A, Sumar N, Bodman K, Goyal S, Sinclair H, Roitt I, Isenberg D (1991) Agalactosyl IgG: an aid to differential diagnosis in early synovitis. Arthritis Rheum 34:1425–1429PubMedCrossRef Young A, Sumar N, Bodman K, Goyal S, Sinclair H, Roitt I, Isenberg D (1991) Agalactosyl IgG: an aid to differential diagnosis in early synovitis. Arthritis Rheum 34:1425–1429PubMedCrossRef
21.
go back to reference Lacki JK, Porawska W, Mackiewicz U, Mackiewicz S, Muller W (1996) Changes in agalactosyl IgG levels correlate with radiological progression in early rheumatoid arthritis. Ann Med 28:265–269PubMed Lacki JK, Porawska W, Mackiewicz U, Mackiewicz S, Muller W (1996) Changes in agalactosyl IgG levels correlate with radiological progression in early rheumatoid arthritis. Ann Med 28:265–269PubMed
22.
go back to reference Tsuchiya N, Endo T, Shiota M, Kochibe N, Ito N, Kobata A (1994) Distribution of glycosylation abnormality among serum IgG subclasses from patients with rheumatoid arthritis. Clin Immunol Immunopathol 70:47–50PubMedCrossRef Tsuchiya N, Endo T, Shiota M, Kochibe N, Ito N, Kobata A (1994) Distribution of glycosylation abnormality among serum IgG subclasses from patients with rheumatoid arthritis. Clin Immunol Immunopathol 70:47–50PubMedCrossRef
23.
go back to reference Van Gestel AM, Haagsma CJ, van Riel PL (1998) Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum 41:1845–1850PubMedCrossRef Van Gestel AM, Haagsma CJ, van Riel PL (1998) Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum 41:1845–1850PubMedCrossRef
24.
go back to reference Saha SK, Brewer CF (1994) Determination of the concentration of oligosaccharides, complex type carbohydrates and glycoproteins using the phenolsulfuric acid method. Carbohydr Res 254:157–167PubMedCrossRef Saha SK, Brewer CF (1994) Determination of the concentration of oligosaccharides, complex type carbohydrates and glycoproteins using the phenolsulfuric acid method. Carbohydr Res 254:157–167PubMedCrossRef
25.
go back to reference Tang W, Matsumoto A, Shikata K, Takeuchi F, Konishi T, Nakata M, Mizuochi T (1998) Detection of disease-specific augmentation of abnormal immunoglobulin G in sera of patients with rheumatoid arthritis. Glycoconj J 15:929–934PubMedCrossRef Tang W, Matsumoto A, Shikata K, Takeuchi F, Konishi T, Nakata M, Mizuochi T (1998) Detection of disease-specific augmentation of abnormal immunoglobulin G in sera of patients with rheumatoid arthritis. Glycoconj J 15:929–934PubMedCrossRef
26.
go back to reference Leader KA, Lastra GC, Kirwan JR, Elson CJ (1996) Agalactosyl IgG in aggregates from the rheumatoid joints. Br J Rheumatol 35:335–341PubMedCrossRef Leader KA, Lastra GC, Kirwan JR, Elson CJ (1996) Agalactosyl IgG in aggregates from the rheumatoid joints. Br J Rheumatol 35:335–341PubMedCrossRef
27.
go back to reference Soltys AJ, Hay FC, Bond A, Oxford JS, Jonem MG, Randek I, Thompson KM, Natvig JB (1994) The binding of synovial tissue-derived human monoclonal immunoglobulin M rheumatoid factor to immunoglobulin G preparations of differing galactose content. Scand J Immunol 40:135–143PubMedCrossRef Soltys AJ, Hay FC, Bond A, Oxford JS, Jonem MG, Randek I, Thompson KM, Natvig JB (1994) The binding of synovial tissue-derived human monoclonal immunoglobulin M rheumatoid factor to immunoglobulin G preparations of differing galactose content. Scand J Immunol 40:135–143PubMedCrossRef
28.
go back to reference Van Zeben D, Rook GA, Hazes JM, Zwinderman AH, Zhang Y, Ghelani S, Rademacher TW, Breedveld FC (1994) Early agalactosylation of IgG is associated with a more progressive disease course in patients with rheumatoid arthritis: results of follow-up study. Br J Rheumatol 3:36–43CrossRef Van Zeben D, Rook GA, Hazes JM, Zwinderman AH, Zhang Y, Ghelani S, Rademacher TW, Breedveld FC (1994) Early agalactosylation of IgG is associated with a more progressive disease course in patients with rheumatoid arthritis: results of follow-up study. Br J Rheumatol 3:36–43CrossRef
29.
go back to reference Bond A, Sumar N, Bodman K, Colacos CB, Young A, Hay FC (1994) Relationship of IgG glycosylation, soluble IL-2 receptors and IL-6 to disease activity in rheumatoid arthritis. Br J Rheumatol 33:992–993PubMedCrossRef Bond A, Sumar N, Bodman K, Colacos CB, Young A, Hay FC (1994) Relationship of IgG glycosylation, soluble IL-2 receptors and IL-6 to disease activity in rheumatoid arthritis. Br J Rheumatol 33:992–993PubMedCrossRef
30.
go back to reference Wormald MR, Rudd PM, Harvey DJ, Chang SC, Scragg IG, Dwek RA (1997) Variations in oligosaccharide–protein interactions in immunoglobulin G determine the site-specific glycosylation profiles and modulate the dynamic motion of the Fc oligosaccharides. Biochemistry 36:1370–1380PubMedCrossRef Wormald MR, Rudd PM, Harvey DJ, Chang SC, Scragg IG, Dwek RA (1997) Variations in oligosaccharide–protein interactions in immunoglobulin G determine the site-specific glycosylation profiles and modulate the dynamic motion of the Fc oligosaccharides. Biochemistry 36:1370–1380PubMedCrossRef
31.
go back to reference Krotkiewski H (1999) Carbohydrate moiety of immunoglobulins in health and pathology. Acta Biochim Pol 46:341–350PubMed Krotkiewski H (1999) Carbohydrate moiety of immunoglobulins in health and pathology. Acta Biochim Pol 46:341–350PubMed
32.
go back to reference Youings A, Chang SC, Dwek RA, Scragg IG (1996) Site-specific glycosylation of human immunoglobulin G is altered in four rheumatoid arthritis patients. Biochem J 314:621–630PubMed Youings A, Chang SC, Dwek RA, Scragg IG (1996) Site-specific glycosylation of human immunoglobulin G is altered in four rheumatoid arthritis patients. Biochem J 314:621–630PubMed
Metadata
Title
The changes in monosaccharide composition of immunoglobulin G in the course of rheumatoid arthritis
Authors
Ewa Gindzienska-Sieskiewicz
Piotr Adrian Klimiuk
Dariusz Gabriel Kisiel
Andrzej Gindzienski
Stanislaw Sierakowski
Publication date
01-05-2007
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 5/2007
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-006-0370-7

Other articles of this Issue 5/2007

Clinical Rheumatology 5/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.